|
Platelet function inhibitors
Citations 1-10 of 248 total displayed.
|
Most recent content
(23 Nov 2009):
|
- Articles
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
- Jeffrey S. Berger, Deepak L. Bhatt, Steven R. Steinhubl, Mingyuan Shao, P. Gabriel Steg, Gilles Montalescot, Werner Hacke, Keith A. Fox, A. Michael Lincoff, Eric J. Topol, Peter B. Berger for the CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance) Investigators
Circulation published November 23, 2009, doi:10.1161/CIRCULATIONAHA.109.866533
[Abstract]
|
Past content
(since Oct 2000):
|
- Articles
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Cornonary Disease: The ONSET/OFFSET Study
- Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler, Udaya S. Tantry, Tania Gesheff, Cheryl Wei, Renli Teng, Mark J. Antonino, Shankar B. Patil, Arun Karunakaran, Dean J. Kereiakes, Cordel Parris, Drew Purdy, Vance Wilson, Gary S. Ledley, and Robert F. Storey
Circulation published November 18, 2009, doi:10.1161/CIRCULATIONAHA.109.912550
[Abstract]
- Articles
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- Frederick G. Kushner, Mary Hand, Sidney C. Smith, Jr, Spencer B. King, III, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Jr, Lee A. Green, Judith S. Hochman, Alice K. Jacobs, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, and David O. Williams
Circulation published November 18, 2009, doi:10.1161/CIRCULATIONAHA.109.192663
[Abstract]
- Correspondence
Letter by de Miguel Castro et al Regarding Article, "Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay: A 12-Month Follow-Up"
- Antonio de Miguel Castro, Alejandro Diego Nieto, and Armando Pérez de Prado
Circulation 2009;120:e98, doi:10.1161/CIRCULATIONAHA.109.863886
[Full text]
- Correspondence
Response to Letter Regarding Article, "Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- Pieter J. Vlaar, Tone Svilaas, Kevin Damman, Bart J.G.L. de Smet, Hans L. Hillege, Felix Zijlstra, and Jan G.P. Tijssen
Circulation 2009;120:e27, doi:10.1161/CIRCULATIONAHA.109.853234
[Full text]
- Correspondence
Letter by Rosenstein and Parra Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38"
- Robert S. Rosenstein and David Parra
Circulation 2009;119:e601, doi:10.1161/CIRCULATIONAHA.108.829838
[Full text]
- Correspondence
Response to Letter Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38"
- Stephen D. Wiviott, Eugene Braunwald, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Dominick J. Angiolillo, Simha Meisel, Anthony J. Dalby, Freek W.A. Verheugt, Shaun G. Goodman, Ramon Corbalan, and Drew A. Purdy
Circulation 2009;119:e602-603e, doi:10.1161/CIRCULATIONAHA.108.844050
[Full text]
- Editorials
Antiplatelet Polypharmacy in Primary Percutaneous Coronary Intervention: Trying to Understand When More Is Better
- Ahmed Abdel-Latif and David J. Moliterno
Circulation 2009;119:3168-3170; published online before print as doi:10.1161/CIRCULATIONAHA.109.874552
[Full text]
- Interventional Cardiology
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Kang-Yin Chen, Seung-Woon Rha, Yong-Jian Li, Kanhaiya L. Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, Young Keun Ahn, Taek Jong Hong, Young Jo Kim, Seung Ho Hur, In Whan Seong, Jei Keon Chae, Myeong Chan Cho, Jang Ho Bae, Dong Hoon Choi, Yang Soo Jang, In Ho Chae, Chong Jin Kim, Jung Han Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park for the Korea Acute Myocardial Infarction Registry Investigators
Circulation 2009;119:3207-3214; published online before print as doi:10.1161/CIRCULATIONAHA.108.822791
[Abstract]
[Full text]
- Correspondence
Letter by Cattaneo Regarding Article, "Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk"
- Marco Cattaneo
Circulation 2009;119:e594, doi:10.1161/CIRCULATIONAHA.108.838888
[Full text]
|
|
